Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer: a multi-institutional phase II study.
about
Polymorphisms in ERCC1, GSTs, TS and MTHFR predict clinical outcomes of gastric cancer patients treated with platinum/5-Fu-based chemotherapy: a systematic reviewPemetrexed for previously treated patients with metastatic gastric cancer: a prospective phase II studyCellular and molecular mechanisms for the synergistic cytotoxicity elicited by oxaliplatin and pemetrexed in colon cancer cell lines.Synchronous lung and gastric cancers successfully treated with carboplatin and pemetrexed: a case report.Polymorphisms in thymidylate synthase and reduced folate carrier (SLC19A1) genes predict survival outcome in advanced non-small cell lung cancer patients treated with pemetrexed-based chemotherapy.Effect of folic acid and vitamin B12 on pemetrexed antifolate chemotherapy in nutrient lung cancer cellsProfiling chemotherapy-associated myelotoxicity among Chinese gastric cancer population receiving cytotoxic conventional regimens: epidemiological features, timing, predictors and clinical impacts.Evaluation of METase-pemetrexed-loaded PEG-PLGA nanoparticles modified with anti-CD133-scFV for treatment of gastric carcinoma.
P2860
Q26824719-5F3DEA6C-3ABC-45E7-BE85-B8A3230E2482Q33419166-0DD08EB0-A852-4365-9D86-0AC8B59006DDQ33914993-54990904-C7FD-4AFB-85E8-2D27D7D5B408Q36233013-9D576351-0674-477A-8526-27ADDCB01C5CQ36774217-9CF5C77F-1793-4D65-9D45-6E485E2A8BD8Q37105343-7A1BA72F-D6D7-4A91-817D-F3700E74E8B3Q41242339-6DCEF6EC-F827-4A54-AB15-EE7D9C241965Q48572985-9F146867-F477-4475-BB6C-845E1CA1F83E
P2860
Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer: a multi-institutional phase II study.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Pemetrexed in combination with ...... -institutional phase II study.
@ast
Pemetrexed in combination with ...... -institutional phase II study.
@en
type
label
Pemetrexed in combination with ...... -institutional phase II study.
@ast
Pemetrexed in combination with ...... -institutional phase II study.
@en
prefLabel
Pemetrexed in combination with ...... -institutional phase II study.
@ast
Pemetrexed in combination with ...... -institutional phase II study.
@en
P2093
P2860
P50
P356
P1433
P1476
Pemetrexed in combination with ...... -institutional phase II study.
@en
P2093
C N Sternberg
F Di Costanzo
I La Torre
P2860
P304
P356
10.1093/ANNONC/MDN766
P577
2009-02-13T00:00:00Z